The Doctor’s Channel

  • Sign In
  • Register
The Doctor’s Channel
  • CME
  • Specialties
  • COVID-19
  • Careers
  • Profile
  • Search

The Oncology Channel

Immune Checkpoint Inhibitor Combination Efficacious for Patients With High-grade Neuroendocrine Carcinoma

8:02 | Apr 12, 2019 | Endocrinology, Oncology

More in Oncology

► 14:41

Discussion of Oncology Paradigm Shifts Over Time

Oncology

Richard Quek, MBBS, a medical oncologist at Mount Elizabeth Hospitals and Gleneagles Hospital, Singapore, discusses the evolution of treatment strategies in oncology. Dr Quek speaks about multidisciplinary cancer care and...

► 21:50

Updates from ESMO 2022 in Colorectal Cancer

Oncology

Chetan Deshmukh, MBBS, a medical oncologist from Deenanath Mangeshkar Hospital and Research Center, Pune, India, discusses the CAIRO5 study, which was presented at the congress, and shares his thoughts on...

► 1:29:36

How Can Metastatic Brain Tumors Affect Lung Cancer Care?

Oncology

Erin Dunbar, MD, director of Neuro-Oncology, Piedmont Atlanta Hospital, Atlanta, GA; Minesh Mehta, MD, chief of Radiotherapy, Baptist Health South Florida; Rohan Ramakrishna, MD, neurosurgeon, Weil Cornell Medical Center, New...

► 3:04

Combination Therapy Options for Blast Phase CML Treatment

CML Content Hub

Mhairi Copland, MBChB, PhD, University of Glasgow, Glasgow, UK, discusses treatment options for blast phase CML, pointing out that TKI therapy alone with ponatinib has a 3-year survival rate of...

More in Oncology…

  • Advertise With Us
  • Careers
  • Partner With Us
  • Privacy Policy
  • Terms of Use

© 2007-2023 The Doctor’s Channel. All rights reserved.